Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Rees

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Prostate|December 29, 2006
Identification of a novel prostate cancer-associated tumor antigenAmanda K Miles, Alistair Rogers, Geng Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunitySelman A Ali, June Lynam, Cornelia S McLean, et al.
Oncotarget|January 20, 2018
The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2Tarek M A Abdel-Fatah, Robert C Rees, A Graham Pockley, et al.
Journal of Immunological Methods|April 7, 2009
Artificial exosomes as tools for basic and clinical immunologyHugo De La Peña, J A Madrigal, Sylvie Rusakiewicz, et al.
Vaccine|August 19, 2004
Anti-tumour therapeutic efficacy of OX40L in murine tumour modelSelman A Ali, Murrium Ahmad, June Lynam, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2007
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptidesMorgan G Mathieu, Ashley J Knights, Graham Pawelec, et al.
European Journal of Immunology|December 17, 2013
Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in miceJaimy M S Saif, Jayakumar Vadakekolathu, Shraddha S Rane, et al.
Biology|February 27, 2020
β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3Michael Gruet, Daniel Cotton, Clare Coveney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Genes, Chromosomes & Cancer|December 11, 2012
Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cellsStéphanie A-S Laversin, Vinaya M Phatak, Des G Powe, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Prostate|December 29, 2006
Identification of a novel prostate cancer-associated tumor antigenAmanda K Miles, Alistair Rogers, Geng Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunitySelman A Ali, June Lynam, Cornelia S McLean, et al.
Oncotarget|January 20, 2018
The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2Tarek M A Abdel-Fatah, Robert C Rees, A Graham Pockley, et al.
Journal of Immunological Methods|April 7, 2009
Artificial exosomes as tools for basic and clinical immunologyHugo De La Peña, J A Madrigal, Sylvie Rusakiewicz, et al.
Vaccine|August 19, 2004
Anti-tumour therapeutic efficacy of OX40L in murine tumour modelSelman A Ali, Murrium Ahmad, June Lynam, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2007
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptidesMorgan G Mathieu, Ashley J Knights, Graham Pawelec, et al.
European Journal of Immunology|December 17, 2013
Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in miceJaimy M S Saif, Jayakumar Vadakekolathu, Shraddha S Rane, et al.
Biology|February 27, 2020
β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3Michael Gruet, Daniel Cotton, Clare Coveney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Genes, Chromosomes & Cancer|December 11, 2012
Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cellsStéphanie A-S Laversin, Vinaya M Phatak, Des G Powe, et al.
Pageof 6